CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary Syndrome Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention High-Sensitivity Troponin and The Application of Risk Stratification Thresholds in Patients with Suspected Acute Coronary Syndrome Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing JACC Scientific Expert Panel MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial

Guideline31 August 2019

JOURNAL:Eur Heart J. Article Link

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)

J Knuuti, W Wijns, ESC Scientific Document Group et al. Keywords: guidelines, chronic coronary syndromes, angina pectoris, myocardial ischaemia, coronary artery disease, diagnostic testing, imaging, risk assessment, lifestyle modifications, anti-ischaemic drugs, antithrombotic therapy, lipid-lowering drugs, myocardial revascularization, microvascular angina, vasospastic angina, screening

FULL TEXT PDF